| Tue, Dec 15, 2009 | | • | Cyclacel Receives NASDAQ Notice of Non-Compliance
GlobeNewswire (Tue, Dec 15)
| | • | Cyclacel Provides Update on Meeting With FDA to Discuss Pivotal Study Design for Sapacitabine
GlobeNewswire (Tue, Dec 15)
| | Sat, Dec 5, 2009 | | • | Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting
GlobeNewswire (Sat, Dec 5)
| | Tue, Dec 1, 2009 | | • | Cyclacel to Host Conference Call on Monday, December 7 to Discuss New Phase 2 Sapacitabine Data to be Presented at ASH
GlobeNewswire (Tue, Dec 1)
| | Mon, Nov 30, 2009 | | • | Sapacitabine Phase 1 Data Published in Acute Leukemia and Myelodysplastic Syndromes
GlobeNewswire (Mon, Nov 30)
| | Tue, Nov 17, 2009 | | • | Cyclacel Pharmaceuticals to Present Sapacitabine Phase 2 AML & MDS Data at the Upcoming American Society of Hematology Meeting
GlobeNewswire (Tue, Nov 17)
| | Tue, Nov 3, 2009 | | • | Cyclacel Pharmaceuticals Announces Third Quarter 2009 Financial Results
GlobeNewswire (Tue, Nov 3)
| | Fri, Oct 30, 2009 | | • | Cyclacel Pharmaceuticals Receives Deficiency Notice From Nasdaq Global Select Market
GlobeNewswire (Fri, Oct 30)
| | Wed, Oct 28, 2009 | | • | Cyclacel Pharmaceuticals Reports Survival Data From Phase 2 Sapacitabine Study in Elderly Patients With Acute Myeloid Leukemia
GlobeNewswire (Wed, Oct 28)
| | • | Cyclacel Pharmaceuticals Third Quarter 2009 Financial Results Conference Call On Tuesday November 3 & Upcoming Conference Presentations
GlobeNewswire (Wed, Oct 28)
| | Wed, Oct 21, 2009 | | • | Cyclacel Pharmaceuticals to Present at BIO Investor Forum
GlobeNewswire (Wed, Oct 21)
| | Thu, Sep 3, 2009 | | • | Cyclacel to Present At Annual Rodman & Renshaw Healthcare Conference
GlobeNewswire (Thu, Sep 3)
| | Fri, Aug 28, 2009 | | • | Cyclacel Pharmaceuticals Announces Receipt of NASDAQ Notice
GlobeNewswire (Fri, Aug 28)
| | Thu, Aug 6, 2009 | | • | Cyclacel Pharmaceuticals Announces Second Quarter 2009 Financial Results
GlobeNewswire (Thu, Aug 6)
| | Fri, Jul 31, 2009 | | • | Cyclacel Pharmaceuticals to Announce Second Quarter 2009 Financial Results On August 6, 2009
GlobeNewswire (Fri, Jul 31)
| | Thu, Jul 30, 2009 | | • | Cyclacel Completes Previously Announced Registered Direct Offering
GlobeNewswire (Thu, Jul 30)
| | Fri, Jul 24, 2009 | | • | Cyclacel to Raise Up to $5.9 Million in Registered Direct Offering
GlobeNewswire (Fri, Jul 24)
| | Tue, Jun 9, 2009 | | • | Cyclacel to Present At Annual Needham Biotechnology and Medical Technology Conference
GlobeNewswire (Tue, Jun 9)
| | Mon, Jun 8, 2009 | | • | Sapacitabine Has Anti-Cancer Activity in Combination With Targeted Agents and Other Nucleoside Analogs
GlobeNewswire (Mon, Jun 8)
| | Fri, May 29, 2009 | | • | Cyclacel Reports Initial Phase 2 Seliciclib Data in Patients With Nasopharyngeal Carcinoma At 2009 ASCO Annual Meeting
GlobeNewswire (Fri, May 29)
|
Add CYCCP News to My Yahoo!:
 
| |
|
0.49% Nasdaq 
Headlines
